ClinConnect ClinConnect Logo
Search / Trial NCT06946056

Evaluation of the Effect of Biofiller PRP Application on Knee Osteoarthritis

Launched by NECMETTIN ERBAKAN UNIVERSITY · Apr 18, 2025

Trial Information

Current as of July 27, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the effects of a treatment called biofiller PRP on people with knee osteoarthritis, a condition that causes pain and stiffness in the knee. The researchers want to see if this treatment can help reduce pain, improve movement, enhance quality of life, and increase the thickness of the cartilage in the knee, which is important for joint health.

To participate in this study, individuals need to be between 45 and 65 years old and have been diagnosed with knee osteoarthritis for at least six months. They should also be experiencing moderate pain. However, people with certain conditions, like a history of knee surgery, inflammatory arthritis, or other serious health issues, will not be eligible. The trial is not currently recruiting participants, but if you qualify, you can expect to receive the biofiller PRP treatment and be monitored for improvements over time. This study aims to provide valuable information on how this treatment might help those suffering from knee osteoarthritis.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1-45-65 years old 2-Diagnosis of knee OA according to ACR clinical and radiological diagnostic criteria 3-Kellgren Lawrence stage II or III 4-Knee pain for at least 6 months 5-Visual analog scale (VAS) score of at least 3 or more
  • Exclusion Criteria:
  • 1 - History of surgery or traumatic injury 2-Inflammatory arthritis 3-History of cancer, bleeding diathesis and psychiatric disease 4-Those who have a disease that limits their participation in exercises (severe chronic obstructive lung disease, severe heart failure, history of cerebrovascular events) 5-Hip and ankle problems 6-Participating in another physical therapy program in the last 3 months 7-History of intra-articular injections in the last 6 months

About Necmettin Erbakan University

Necmettin Erbakan University is a prominent academic institution dedicated to advancing health sciences and research through innovative clinical trials. With a commitment to excellence in education and research, the university leverages its multidisciplinary approach to foster collaborations that enhance patient care and medical advancements. By conducting rigorous clinical studies, Necmettin Erbakan University seeks to contribute valuable insights to the medical community, ultimately improving treatment outcomes and fostering evidence-based practices in healthcare.

Locations

Patients applied

0 patients applied

Trial Officials

BANU ORDAHAN

Principal Investigator

Necmettin Erbakan University, Konya, Turkey

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported